{
	"sid": 16413240 ,
	"pkdb_version": 1.0,
	"creator": "admin",
	"name": "test_study",
	"design": null,
	"keywords":[],
	"reference": 16413240,
	"descriptions":["Our objective was to investigate whether codeine or one of its metabolites contributes substantially to central nervous effects independent from the cytochrome P450 (CYP) 2D6 â€“mediated O-demethylation to morphine."],
	"curators": [
		"admin"
	],
	"substances": [
		"codeine"
	],
	"groupset": {
	"descriptions": ["The method was applied to determine the plasma concentrations of codeine and its metabolite morphine from a clinical trial study in which 20 healthy male volunteers each received orally a tablet containing 30 mg codeine phosphate."],
		"groups":[
			{
				"name":"all",
			  "count":11,
			  "characteristica":
				[
					{
					  "category": "species",
					  "choice": "homo sapiens"
					},
					{
					  "category": "healthy",
					  "choice": "Y"
					},
					{
						"category":"overnight fast",
						"choice":"Y"
					},
					{
						"category":"abstinence",
						"choice":"drug",
						"value": 4,
						"unit": "week",
						"comments":[["janekg","the regular use of drugs including those of herbal origin was not allowed from 4 weeks before the study up to the end of the study period, with the exception of oral contraceptives, and 2 weeks before each study day, the use of over-the-counter drugs was prohibited."]]
					},
					{
						"category":"ethnicity",
						"choice":"caucasian"
					}
				]
			}
		]
	},
	"individualset": {
		"descriptions":[],
		"individuals":
		[
			{
				"group":"all",
				"source":"test_study_Tab1.csv",
				"format":"TSV",
				"name":"col==subject",
				"characteristica":[
					{
						"category":"phenotype",
						"choice":"col==metaboliser_type"
					},
					{
						"category":"sex",
						"choice":"col==sex"
					},
					{
						"category":"age",
						"value":"col==age",
						"unit":"yr"
					},
					{
						"category":"weight",
						"value":"col==weight",
						"unit":"kg"
					},
					{
						"category":"CYP2D6 genotype",
						"choice":"col==CYP2D6_genotype"
					}
					]
			}
		]
	},
	"interventionset":
		{
			"descriptions":[""],
			"interventions":
			[
			  	{
					"name": "COD",
					"substance": "codeine",
					"time": "0",
					"time_unit": "h",
					"route": "oral",
					"form":"tablet",
					"value": 30,
					"unit": "mg",
					"category": "dosing"
				},
				{
				"name": "MOR",
				"substance": "morphine",
				"time": "0",
				"time_unit": "h",
				"route": "iv",
				"value": 30,
				"unit": "mg",
				"category": "dosing"
			}
			]
		},
"outputset": {
		"descriptions":[],
		"outputs":[],
		"timecourses":[
					{"figure":"test_study_Fig2.png",
					 "source":"test_study_Fig2.csv",
					 "format":"TSV",
					 "pktype":"concentration",
					 "tissue":"plasma",
					 "subset":"intervention==codeine",
					 "groupby":"subject",
					 "interventions":["COD"],
					 "individual":"col==subject",
	 				 "substance":"codeine || codeine-6-glucuronide || norcodeine || morphine || morphine-6-glucuronide || normorphine",
					 "time":"col==time",
					 "time_unit":"h",
					 "unit":"nmol/ml",
					 "value":"col==plasma_codeine || col==plasma_C6G || col==plasma_norcodeine ||  col==plasma_morphine || col==plasma_M6G || col==plasma_normorphine"
				 },
				 {"figure":"test_study_Fig2.png",
					"source":"test_study_Fig2.csv",
					"format":"TSV",
					"pktype":"concentration",
					"tissue":"plasma",
					"subset":"intervention==morphine",
					"groupby":"subject",
					"interventions":["MOR"],
					"individual":"col==subject",
					"substance":"codeine || codeine-6-glucuronide || norcodeine || morphine || morphine-6-glucuronide || normorphine",
					"time":"col==time",
					"time_unit":"h",
					"unit":"nmol/ml",
					"value":"col==plasma_codeine || col==plasma_C6G || col==plasma_norcodeine ||  col==plasma_morphine || col==plasma_M6G || col==plasma_normorphine"
				}
			]

		}
}
